Roche announced today positive topline results from two arms of an ongoing multi-part Phase I clinical trial for CT-996, an investigational, once-daily, oral small molecule GLP-1 receptor agonist being developed for the treatment of both type 2 diabetes and obesity
I guess new year still means mean people." This year, she shared more of her thoughts on an episode of The Kardashians
A phase 3 programme evaluating retatrutide across multiple populations including adults with obesity, adults with type 2 diabetes, and individuals with obesity-related comorbidities is under way
Youll get carnitine from meat, fish, poultry, and milk
Once we determine you are a good candidate, well take pictures and measurements to track your progress and review your lab results before beginning treatment
Weight loss is modest, typically 1 to 3 pounds, as the dose is at the starting level